The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(cyclooctanecarboxamido)phenyl benzenesulfonate ID: ALA4537293
PubChem CID: 155548086
Max Phase: Preclinical
Molecular Formula: C21H25NO4S
Molecular Weight: 387.50
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccc(OS(=O)(=O)c2ccccc2)cc1)C1CCCCCCC1
Standard InChI: InChI=1S/C21H25NO4S/c23-21(17-9-5-2-1-3-6-10-17)22-18-13-15-19(16-14-18)26-27(24,25)20-11-7-4-8-12-20/h4,7-8,11-17H,1-3,5-6,9-10H2,(H,22,23)
Standard InChI Key: SQJFTHOUCMXTJO-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
22.0931 -25.7580 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.5058 -26.4679 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.9142 -25.7555 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.9241 -25.6507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9230 -26.4702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6310 -26.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3407 -26.4698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3379 -25.6471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6292 -25.2418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0440 -25.2358 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.7533 -25.6418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4594 -25.2305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7563 -26.4589 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.2150 -26.8783 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.7995 -26.8771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0928 -26.4679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3870 -26.8765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3878 -27.6936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1003 -28.1004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8032 -27.6896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4128 -24.3703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4316 -25.1894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8687 -25.7789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8231 -23.8073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0041 -23.8261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4410 -24.4158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0495 -25.7979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
5 14 1 0
14 2 1 0
2 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
21 22 1 0
22 23 1 0
21 24 1 0
24 25 1 0
25 26 1 0
26 12 1 0
12 27 1 0
27 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 387.50Molecular Weight (Monoisotopic): 387.1504AlogP: 4.75#Rotatable Bonds: 5Polar Surface Area: 72.47Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 5.43CX LogD: 5.43Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.75Np Likeness Score: -1.19
References 1. Semreen MH, El-Gamal MI, Ullah S, Jalil S, Zaib S, Anbar HS, Lecka J, Sévigny J, Iqbal J.. (2019) Synthesis, biological evaluation, and molecular docking study of sulfonate derivatives as nucleotide pyrophosphatase/phosphodiesterase (NPP) inhibitors., 27 (13): [PMID:31088715 ] [10.1016/j.bmc.2019.04.031 ]